Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Julie Michele Cherrington
EtÓ : 62
Patrimonio pubblico : 250 352 USD
Principali societÓ : Mirati Therapeutics, Inc. - Vaxart, Inc. - Rakovina Therapeutics Inc.
Riassunto 
Dr. Julie M. Cherrington is an Independent Director at Vaxart, Inc., a Chief Executive Officer & Director at QUE Oncology, Inc., an Independent Director at Mirati Therapeutics, Inc., a Member at American Diabetes Association, a Member at American Society of Clinical Oncology and a Member at American Society of Hematology.

She is on the Board of Directors at Vaxart, Inc., Rakovina Therapeutics, Inc., QUE Oncology, Inc. and Mirati Therapeutics, Inc. Dr. Cherrington was previously employed as a President, Chief Executive Officer & Director by Arch Oncology, Inc., a President, Chief Executive Officer & Director by Pathway Therapeutics Ltd., a President, Chief Executive Officer & Director by Pathway Therapeutics, Inc., an Independent Non-Executive Director by Progen Pharmaceuticals Ltd., an Independent Non-Executive Director by ChemGenex Pharmaceuticals Pty Ltd., a President by Phenomix Australia Pty Ltd., a President by Phenomix Corp., a VP-Preclinical Research & Exploratory Development by SUGEN LLC, a Member by American Association for Cancer Research, a Virology Director by Gilead Sciences, Inc., a President & Chief Executive Officer by Revitope Oncology, Inc., a Chairman by Xenome Ltd., and a President & Chief Executive Officer by Zenith Capital Corp. (Alberta).

She also served on the board at Leading Biosciences, Inc.

She received her undergraduate degree from the University of California, Davis, a graduate degree from the University of California, Davis and a doctorate degree from the University of Minnesota.


Posti e reponsabilitÓ di Julie Michele Cherrington 
NomeTitolo Da
Mirati Therapeutics, Inc.
(Biotecnologia)
Independent Director 2019
Vaxart, Inc.
(Biotecnologia)
Independent Director 2021
Rakovina Therapeutics Inc.
(Biotecnologia)
Director 2021
QUE Oncology, Inc. Chief Executive Officer & Director 2020
American Diabetes Association Member -
American Society of Clinical Oncology Member -
American Society of Hematology Member -


Participazioni di Julie Michele Cherrington 
NomeAzioni%Valorizzazione
Mirati Therapeutics, Inc. (MRTX)
(Biotecnologia)
1 4750,0029%250 352 USD
Rakovina Therapeutics Inc. (RKV)
(Biotecnologia)
00,0000%0 USD


Julie Michele Cherrington: network personale 
Le notizie pi¨ lette 
22/09WILLIAM ACKMAN: Il fondo Pershing Square di Ackman sale mentre Universal sale al debutto in borsa
MR
24/09CATHIE WOOD: Il giro di vite cinese sul bitcoin è un altro colpo per l'ARK ETF di Cathie Wood
MR
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
13/09MARTIN SORRELL: S4 Capital di Sorrell alza le prospettive di profitto al 40%
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
24/09ELON MUSK: Auto, con nuovi impianti semiconduttori carenza chip avrà vita breve - Musk (Tesla)
RE
24/09LUIGI GUBITOSI: Tim, offerta per polo nazionale cloud in arrivo a breve - Gubitosi
RE
24/09PHILIPPE DONNET: Generali, comitato nomine a maggioranza propone lista Cda con Donnet Ceo - fonti
RE
22/09JOHN ELKANN: Stellantis, Torino è città chiave per produzione gruppo - Elkann
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
Pi¨ notizie


© 2021 People and Ownership :   
Julie Michele Cherrington : connessioni